Return
Injectable PLCL/CaHA Composite Hydrogel Drives Angiogenic Osteogenesis via Endothelial Sphingosine-1-Phosphate Signaling
Q
D
X
D
Y
S
L
Y
DOI:10.1016/j.tca.2026.180373.png)
Abstract
En 中文
• Injectable PLCL/CaHA hydrogel enables vascularized bone regeneration. • PLCL/CaHA hydrogel promotes endothelial activation and angiogenesis. • PLCL/CaHA hydrogel enhances early vascularization in cranial defects. • S1P/S1PR-RAC1 signaling drives angiogenic osteogenesis.
Journal
IF:
3.5
Papers:
9.5K
Citations:
1.9W
